Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions

Clinical trial NCT00029224 · COMPLETED

Trial details

NCT number: NCT00029224
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Breast Cancer Multiple Myeloma Prostate Cancer

Start date: 2001-10-01
Primary completion: 2002-11-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.